Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

892 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Whole-Genome Sequencing to Evaluate the Resistance Landscape Following Antimalarial Treatment Failure With Fosmidomycin-Clindamycin.
Guggisberg AM, Sundararaman SA, Lanaspa M, Moraleda C, González R, Mayor A, Cisteró P, Hutchinson D, Kremsner PG, Hahn BH, Bassat Q, Odom AR. Guggisberg AM, et al. Among authors: hutchinson d. J Infect Dis. 2016 Oct 1;214(7):1085-91. doi: 10.1093/infdis/jiw304. Epub 2016 Jul 20. J Infect Dis. 2016. PMID: 27443612 Free PMC article.
Inadequate efficacy of a new formulation of fosmidomycin-clindamycin combination in Mozambican children less than three years old with uncomplicated Plasmodium falciparum malaria.
Lanaspa M, Moraleda C, Machevo S, González R, Serrano B, Macete E, Cisteró P, Mayor A, Hutchinson D, Kremsner PG, Alonso P, Menéndez C, Bassat Q. Lanaspa M, et al. Among authors: hutchinson d. Antimicrob Agents Chemother. 2012 Jun;56(6):2923-8. doi: 10.1128/AAC.00018-12. Epub 2012 Mar 19. Antimicrob Agents Chemother. 2012. PMID: 22430959 Free PMC article. Clinical Trial.
Fosmidomycin, a novel chemotherapeutic agent for malaria.
Lell B, Ruangweerayut R, Wiesner J, Missinou MA, Schindler A, Baranek T, Hintz M, Hutchinson D, Jomaa H, Kremsner PG. Lell B, et al. Among authors: hutchinson d. Antimicrob Agents Chemother. 2003 Feb;47(2):735-8. doi: 10.1128/AAC.47.2.735-738.2003. Antimicrob Agents Chemother. 2003. PMID: 12543685 Free PMC article. Clinical Trial.
Short-course regimens of artesunate-fosmidomycin in treatment of uncomplicated Plasmodium falciparum malaria.
Borrmann S, Adegnika AA, Moussavou F, Oyakhirome S, Esser G, Matsiegui PB, Ramharter M, Lundgren I, Kombila M, Issifou S, Hutchinson D, Wiesner J, Jomaa H, Kremsner PG. Borrmann S, et al. Among authors: hutchinson d. Antimicrob Agents Chemother. 2005 Sep;49(9):3749-54. doi: 10.1128/AAC.49.9.3749-3754.2005. Antimicrob Agents Chemother. 2005. PMID: 16127049 Free PMC article. Clinical Trial.
Fosmidomycin plus clindamycin for treatment of pediatric patients aged 1 to 14 years with Plasmodium falciparum malaria.
Borrmann S, Lundgren I, Oyakhirome S, Impouma B, Matsiegui PB, Adegnika AA, Issifou S, Kun JF, Hutchinson D, Wiesner J, Jomaa H, Kremsner PG. Borrmann S, et al. Among authors: hutchinson d. Antimicrob Agents Chemother. 2006 Aug;50(8):2713-8. doi: 10.1128/AAC.00392-06. Antimicrob Agents Chemother. 2006. PMID: 16870763 Free PMC article. Clinical Trial.
Efficacy and Safety of Fosmidomycin-Piperaquine as Nonartemisinin-Based Combination Therapy for Uncomplicated Falciparum Malaria: A Single-Arm, Age De-escalation Proof-of-Concept Study in Gabon.
Mombo-Ngoma G, Remppis J, Sievers M, Zoleko Manego R, Endamne L, Kabwende L, Veletzky L, Nguyen TT, Groger M, Lötsch F, Mischlinger J, Flohr L, Kim J, Cattaneo C, Hutchinson D, Duparc S, Moehrle J, Velavan TP, Lell B, Ramharter M, Adegnika AA, Mordmüller B, Kremsner PG. Mombo-Ngoma G, et al. Among authors: hutchinson d. Clin Infect Dis. 2018 Jun 1;66(12):1823-1830. doi: 10.1093/cid/cix1122. Clin Infect Dis. 2018. PMID: 29293893 Free PMC article. Clinical Trial.
Atovaquone and proguanil for Plasmodium falciparum malaria.
Radloff PD, Philipps J, Nkeyi M, Hutchinson D, Kremsner PG. Radloff PD, et al. Among authors: hutchinson d. Lancet. 1996 Jun 1;347(9014):1511-4. doi: 10.1016/s0140-6736(96)90671-6. Lancet. 1996. PMID: 8684102 Clinical Trial.
892 results